Johnson & Johnson (JNJ) Q4 earnings
Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to…
Six key takeaways from the Scottish Hospitals Inquiry
BBC Much of the inquiry evidence has focused on infections at the Royal Hospital for Children The Scottish…
Explained: Why is UAE reviewing medicine prices? What can lower drug bills in Emirates?
UAE Medicine Prices Under Review: Addressing Cost Gaps and Affordability Medicine pricing has become a flashpoint in the…
Novo Holdings buys 49% stake in Surya Hospitals
New Delhi: Novo Holdings, a 142 billion euro investment firm that controls Danish drug maker Novo Nordisk, has…
My friends in Italy are using AI therapists. But is that so bad, when a stigma surrounds mental health? | Viola Di Grado
It’s a sunny afternoon in a Roman park and a peculiar, new-to-this-era kind of coming out is happening…
Is ChatGPT Health the new WebMD?
For a few days around Christmas, Holly Jespersen, a 50-year-old living in New York, did not feel great.…
Wellington Hospital Emergency Department went into code red nearly twice a day in 2025
More than 3200 patients left the emergency department without being treated. Photo: RNZ / REECE BAKER Wellington Hospital’s…
Minister says Alberta emergency room deaths and poor outcomes are exceptions to the norm
As Alberta doctors raise red flags about seeing what they say are delays in emergency room care, the…
A stronger focus on prevention could help governments rein in health care and social spending
At the start of the new year, many of us will commit to joining a gym, eating healthier…
Is Oral Wegovy a Game Changer for Novo Nordisk?
The past couple of years have been challenging for the company. But this could be the beginning of…
Why Israel should put video games at the center of its health-tech strategy
A Type 1 diabetes diagnosis is a traumatic event. Overnight, a patient (or parent) becomes responsible for administering…
Pfizer trims its pan-KRAS efforts | ApexOnco
Pfizer is continuing its new-year clearout, ditching two more projects: the pan-KRAS inhibitor PF-07985045 and the PD-L1-targeting conjugate…